|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.16 USD | +1.75% |
|
+4.50% | -12.78% |
| May. 13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
| May. 09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Co-Diagnostics, Inc. announced revenue guidance for the first quarter of 2022. For the quarter, the company expected revenue in the range of $21.0 million to $22.0 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.78% | 35.64M | |
| -41.48% | 2.95B | |
| +19.36% | 1.88B | |
| -1.05% | 1.63B | |
| +33.96% | 1.34B | |
| -16.83% | 959M | |
| -21.96% | 888M | |
| +7.07% | 842M | |
| -26.10% | 623M | |
| +10.85% | 513M |
CO-DIAGNOSTICS, INC. 